Liver Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Retrospective and Prospective Study Aimed at the Pharmacoeconomic Evaluation of the Cost/Effectiveness Ratio of Physical Exercise on the Prognosis of Non-alcoholic Fatty Liver Disease (NAFLD): Exercise as a Drug
Condition:   NAFLD Intervention:   Sponsors:   Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis;   Antonella Bianco;   Pietro Trisolini;   Giuseppe Dalfino Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials

A Trial to Learn if Having ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor
Conditions:   Nonalcoholic Steatohepatitis;   Genetic Risk Factor Interventions:   Drug: ALN-PNP Dose Level 1;   Drug: ALN-PNP Dose Level 2;   Drug: ALN-PNP Dose Level 3;   Drug: Matching Placebo Sponsor:   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials